1 / 2

Dr Reddy's Launches Anti-nausea Injection for Cancer Patients in US

Read more about Dr Reddy's launches anti-nausea injection for cancer patients in US on Business Standard. Drug is a therapeutic equivalent of USFDA-approved Aloxi injection, whose sales in 12 months to Jan 2018 were $446 mn

priya32438
Download Presentation

Dr Reddy's Launches Anti-nausea Injection for Cancer Patients in US

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Dr Reddy's launches anti-nausea injection for cancer patients in US Dr Reddy's Laboratories Limited announced on Monday that it has launched Palonosetron Hydrochloride Injection, 0.25 mg/ml, a therapeutic equivalent of Aloxi Injection approved by the US Food and Drug Administration (USFDA). The drug is used to treat chemotherapy-induced nausea and vomiting sensation. The Aloxi brand and generic had US sales of approximately $446 million for twelve months ending in January 2018, according to IMS Health. Dr Reddy's injection is available in a single-dose vial packed in a carton containing one vial, according to the company.

  2. The shares of the company were trading at Rs 2,060, down 0.67 per cent, at around 11:30 a.m. on the Bombay Stock Exchange on Monday. Article By - Business Standard

More Related